5.4

CVE-2023-22868: IBM Aspera Faspex cross-site scripting

Modified
Published 17-02-2023Last modified 12-03-2025

Vulnerability summary

CVE-2023-22868 is a medium (CVSS 5.4) vulnerability in ibm aspera_faspex. EPSS estimates a 0.40% chance of exploitation in the next 30 days, higher than 35% of scored vulnerabilities.

Priority
Routine

Not severe (CVSS 5.4, network access); no exploitation reported by the 5 checked sources

Source freshness unavailable

How is this decided?
CVSS score
5.4/10
010
Medium · v3.1 (CVE.org)
EPSS score
0.40%
0%100%
Low · 0.00 pp in 30 days
KEVNot listedNot listed by any tracked catalog.
RansomwareNot flaggedNo ransomware use recorded.
Public exploits0No public exploits recorded

Timeline

  1. 17-02-2023
    PublishedVulnerability first disclosed.
  2. 12-03-2025
    Last modifiedVulnerability information updated.

Description

IBM Aspera Faspex 4.4.1 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 244117.

CVSS metrics

2 scores · 2 sources · 1 version

EPSS trend

Probability

0.40%

Chance of exploitation in the next 30 days

Percentile

35%

Versus all other CVEs

30-day change

No change 0.00 pp

From 0.40% on 11-10-2026

11-10-202610-11-2026

Known exploited

Compare KEV catalogs
CISA KEV

Not in the CISA KEV catalog.

ENISA CNW

Not in the ENISA CNW catalog.

CIRCL

Not in the CIRCL catalog.

Public exploits

0 found

No public exploits indexed.

Weaknesses

CWE · root cause

Affected systems

Version check

Known conditions: network-reachable, low-privilege account, user interaction (CVSS vector). Other conditions: not stated in public data.

Ibm1 product

1 vendor · 1 product

References

2 links